Similar Search Results

Determinants of opposition against EPO patent grants : the case of biotechnology and pharmaceuticals

Harhoff, Dietmar; Reitzig, Markus - In: International journal of industrial organization 22 (2004) 4, pp. 443-480

Persistent link: https://www.econbiz.de/10002010027

Strategien zur Gewinnmaximierung bei der Anmeldung von Patenten : wirtschaftliche und rechtliche Aspekte als Entscheidungsgrößen beim Schutz von Erfindungen

Harhoff, Dietmar; Reitzig, Markus - In: Journal of business economics : JBE 71 (2001) 5, pp. 509-529

Persistent link: https://www.econbiz.de/10001577257

Determinants of opposition against EPO patent grants - the case of biotechnology and pharmaceuticals

Harhoff, Dietmar - 2002

Persistent link: https://www.econbiz.de/10013424211

Collateral damage for R&D manufacturers : how patent sharks operate in markets for technology

Reitzig, Markus; Henkel, Joachim; Schneider, Ferdinand - In: Industrial and corporate change 19 (2010) 3, pp. 947-967

Persistent link: https://www.econbiz.de/10008647592

Comparing the value revelance of R&D reporting in Germany : standard and selection effects

Ramb, Fred; Reitzig, Markus - 2005

On the basis of accounting and market data for firms and groups listed on German stock exchanges between 1997 and 2003, we show that the value relevance of R&D information under German accounting standards can be superior to that provided by US-GAAP and IAS. The results, obtained while...